Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-01-11
2011-01-11
Crouch, Deborah (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S383000
Reexamination Certificate
active
07867974
ABSTRACT:
Disclosed herein is a simple method for the treatment of antigen-deficiency diseases, by orally administering to a subject a therapeutically effective amount of the deficient antigen, wherein the antigen is not present in a liposome. In one embodiment, the method increases hemostasis in a subject having hemophilia A or B, by orally administering to the hemophiliac a therapeutically effective amount of the appropriate clotting factor other than in a liposome, sufficient to induce oral tolerance and supply exogenous clotting factor to the subject.
REFERENCES:
patent: 4348384 (1982-09-01), Horikoshi et al.
patent: 4873316 (1989-10-01), Meade et al.
patent: 5589604 (1996-12-01), Drohan et al.
patent: 5880327 (1999-03-01), Lubdon et al.
patent: 5948407 (1999-09-01), McGuinness et al.
patent: 6046380 (2000-04-01), Clark
patent: 6221349 (2001-04-01), Couto et al.
patent: 6255554 (2001-07-01), Lubon et al.
patent: 6344596 (2002-02-01), Velander et al.
patent: 2004/0117862 (2004-06-01), Cooper et al.
patent: 0 294 910 (1988-12-01), None
patent: WO 80/01456 (1980-07-01), None
patent: WO 95/27512 (1995-10-01), None
Clark et al,. “The Molecular Manipulation of Milk Composition,”Genome31:950-955 (1989).
Hemker et al., “Oral Treatment of Haemophilia A by Gastrointestinal Absorption of Factor VIII Entrapped in Liposomes,”The Lancet, pp. 70-71, Jan. 12, 1980.
Hennighausen, “Transgenic Factor VIII: The Milky Way and Beyond,”Nature Biotechnol. 15:945-946 (1997).
High, “Gene-Based Approaches to the Treatment of Hemophilia,”Ann, N.Y. Acad. Sci, 961:63-64 (2002).
Kaplan et al., “Factor VIII Inhibitors. Potential for Prevention of Inhibitor Formation by Immune Tolerance,”Semin Thromb Hemost. 26:173-178 2000.
Kay et al., “Gene Therapy for the Hemophilias,”Proc. Natl. Acad. Sci. USA96:9973-9975 (1999).
Lindgren et al., “Does Peroral Administration of Factor VIII Induce Oral Tolerance in Patients with Acquired Haemophilia A?,”Throm Haemost83:632-633 (2000).
Mariani et al., “Immune Tolerance to Factor VIII: The International Registry Data,”Adv. Exp. Med. Biol. 386:201-208 (1995).
Morcoöl et al., “The Porcine Mammary Gland as a Bioreactor for Complex Proteins,”Ann. N.Y. Acad. Sci. 2:218-233 (1994).
Niemann et al., “Expression of Human Blood Clotting Factor VIII in the Mammary Gland of Transgenic Sheep ”Transgenic Res. 8:237-247 1999).
Paleyanda et al., “Transgenic Pigs Produce Functional Human Factor VIII in Milk,”Nature Biotechnol. 15:971-975 (1997).
Bolton-Maggs and Pasi, “Haemophilias A and B,”Lancet361:1801-1809 (2003).
Roberts, “Induction of Immune Tolerance to Factor VIII: A Plea for Caution,”JAMA259:84-85 (1988).
Terada et al., “Is Oral Tolerance Therapy Possible for Haemophilia with Inhibitors?,”Vox Sang80:61-62 (2001).
Udall et al., “Development of Gastrointestinal Mucosal Barrier. I. The Effect of Age on Intestinal Permeability to Macromolecules,”Pediatr. Res. 15:241-244 (1981).
Velander et al., “Transgenic Livestock as Drug Factories,”Sci Am. 276:70-74 (1997).
Warshaw et al., “Intestinal Absorption of Intake Antigenic Protein,”Surgery76:495-499 (1974).
Wilmut et al., “Modification of Milk Composition,”J. Reprod. Fert. Suppl. 41:135-146 (1990).
Yee et al., “Oral Immune Tolerance Induction to Factor VIII Via Breast Milk, a Possibility?,”Haemophilia6:591 (2000).
Alpan Oral
Kamala Tirumalai
Matzinger Polly
Velander William Hugold
Crouch Deborah
Klarquist & Sparkman, LLP
The United States of America as represented by the Department of
Virginia Tech Intellectual Properties Inc.
LandOfFree
Induction of tolerance by oral administration of factor VIII... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Induction of tolerance by oral administration of factor VIII..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Induction of tolerance by oral administration of factor VIII... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2704042